UPDATE ON SCHIZOPHRENIA – A U.K. study reports that time to hospitalization was significantly delayed in patients with schizophrenia or schizoaffective disorder discharged on clozapine rather than on another antipsychotic medication (Nyakyoma & Morriss. Psychopharmacol Bull 2010; 43: 67-81).
Latest News
MS incidence higher in African Americans
April 15, 2011REPORT FROM THE 63rd ANNUAL MEETING OF THE AMERICAN ACADEMY OF NEUROLOGY (AAN), HONOLULU, HAWAII, APRIL 9-16, 2011 – MS is generally described as a disease that primarily affects Caucasians, however, a new study from southern California suggests that the incidence is higher in African Americans than in other racial/ethnic groups (Langer-Gould et al. AAN 2011; abstract P06.032).
Comorbidities common, delay MS diagnosis
April 15, 2011REPORT FROM THE 63rd ANNUAL MEETING OF THE AMERICAN ACADEMY OF NEUROLOGY (AAN), HONOLULU, HAWAII, APRIL 9-16, 2011 – The U.S. National Health and Wellness Survey, an annual internet survey of health behaviours, reports that people with MS more commonly report comorbidities compared to those in the general population (Meletiche et al. AAN 2011; abstract P06.045).
Fingolimod: disease-free rates and effect on brain atrophy
April 15, 2011REPORT FROM THE 63rd ANNUAL MEETING OF THE AMERICAN ACADEMY OF NEUROLOGY (AAN), HONOLULU, HAWAII, APRIL 9-16, 2011 – Two analyses of data from the phase III FREEDOMS trial report that fingolimod increases the proportion of MS patients who are disease-free and reduces brain atrophy compared to placebo.